Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.
Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases.
J Epidemiol. 2023 Oct 5;33(10):536-542. doi: 10.2188/jea.JE20220063. Epub 2023 Jan 31.
Limited reports from prospective human studies investigated the possible role of vitamin K in the development of lung cancer although vitamin K's anticarcinogenic activities were verified from several in vitro and in vivo studies. We investigated the associations between total vitamin K intake from food and the development of lung cancer based on this large prospective cohort study.
A validated food frequency questionnaire was used to examine vitamin K intake among 42,166 (16,341 men and 25,825 women) at the Japan Collaborative Cohort Study's baseline (1988-1990). Hazard ratios (HRs) and 95% confidence intervals (CIs) of incident lung cancer were calculated using the Cox proportional hazard regression method based on vitamin K consumption quartiles.
430 cases (308 males and 122 women) of lung cancer were documented during a total of 564,127 person-years of follow-up (median follow-up, 14.6 years). Vitamin K consumption was shown to be inversely related to lung cancer risk; the multivariable hazard ratio [HR] for the highest versus lowest quartiles was 0.67 (95% confidence interval [CI], 0.46-0.96; P for trend = 0.010). This relationship appears to be stronger in males (HR 0.62; 95% CI, 0.40-0.96; P for trend = 0.016) than in females (HR 0.82; 95% CI, 0.42-1.61; P for trend = 0.39) (P for interaction = 0.012), and in ever smokers (HR 0.57; 95% CI, 0.36-0.91; P for trend = 0.006) than in never smokers (HR 0.79; 95% CI, 0.40-1.55; P for trend = 0.37) (P for interaction = 0.30). The individuals' age, body mass index, or alcohol consumption status had no effect on the observed connection.
Vitamin K consumption reduces the risk of lung cancer. More research is needed to clarify the molecular processes behind this connection.
尽管多项体外和体内研究证实了维生素 K 的抗癌活性,但仅有少量来自前瞻性人体研究的报告探讨了维生素 K 对肺癌发展的可能作用。基于这项大型前瞻性队列研究,我们调查了食物中总维生素 K 摄入量与肺癌发展之间的关联。
在日本癌症协作队列研究的基线(1988-1990 年)时,使用经过验证的食物频率问卷来检查 42166 名参与者(16341 名男性和 25825 名女性)的维生素 K 摄入量。基于维生素 K 摄入量四分位数,使用 Cox 比例风险回归方法计算了肺癌发病的风险比(HR)和 95%置信区间(CI)。
在总计 564127 人年的随访期间(中位随访时间 14.6 年),共记录了 430 例肺癌病例(308 例男性和 122 例女性)。维生素 K 摄入量与肺癌风险呈负相关;最高四分位与最低四分位相比,多变量 HR 为 0.67(95%CI,0.46-0.96;趋势 P 值=0.010)。这种关系在男性中似乎更强(HR 0.62;95%CI,0.40-0.96;趋势 P 值=0.016),而在女性中则较弱(HR 0.82;95%CI,0.42-1.61;趋势 P 值=0.39)(交互 P 值=0.012),在曾吸烟者中(HR 0.57;95%CI,0.36-0.91;趋势 P 值=0.006),而在从不吸烟者中则较弱(HR 0.79;95%CI,0.40-1.55;趋势 P 值=0.37)(交互 P 值=0.30)。观察到的关联不受参与者年龄、体重指数或饮酒状况的影响。
维生素 K 摄入量可降低肺癌风险。需要进一步研究以阐明这种关联背后的分子机制。